|
John A. Yarmuth
|
house |
Bristol-myers squibb Company (BmY) |
BMY |
STOCK |
Purchase
|
Dec. 21, 2017 |
$$1,001 - $15,000 |
Aug. 1, 2018 |
|
Shelley M Capito
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Sale (Partial)
|
Oct. 26, 2017 |
$$1,001 - $15,000 |
Nov. 7, 2017 |
|
Alan S. Lowenthal
|
house |
Bristol-Myers Squibb Company (BMY) |
BMY |
STOCK |
Sale
|
Sept. 25, 2017 |
$$15,001 - $50,000 |
Oct. 10, 2017 |
|
Pat Roberts
|
senate |
Celgene Corporation |
BMY |
STOCK |
Sale (Full)
|
Sept. 7, 2017 |
$$15,001 - $50,000 |
Dec. 1, 2017 |
|
Pat Roberts
|
senate |
Celgene Corporation |
BMY |
STOCK |
Sale (Full)
|
Sept. 7, 2017 |
$$1,001 - $15,000 |
Sept. 29, 2017 |
|
Thomas R Carper
|
senate |
Bristol Myers Squibb |
BMY |
STOCK |
Purchase
|
Aug. 31, 2017 |
$$1,001 - $15,000 |
Sept. 6, 2017 |
|
John Rutherford
|
house |
Bristol-Myers Squibb Company (BMY) |
BMY |
STOCK |
Purchase
|
Aug. 16, 2017 |
$$1,001 - $15,000 |
Aug. 20, 2018 |
|
Pat Roberts
|
senate |
Celgene Corporation |
BMY |
STOCK |
Purchase
|
Aug. 1, 2017 |
$$15,001 - $50,000 |
Sept. 4, 2017 |
|
Alan S. Lowenthal
|
house |
Bristol-Myers Squibb Company (BMY) |
BMY |
STOCK |
Purchase
|
July 27, 2017 |
$$15,001 - $50,000 |
Aug. 13, 2017 |
|
James B. Renacci
|
house |
BRISTO-MYERS SQUIBB COMPANY (BMSY) |
BMY |
STOCK |
PURCHASE
|
July 19, 2017 |
$$15,001 - $50,000 |
Aug. 10, 2017 |
|
Sheldon Whitehouse
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Sale (Partial)
|
July 13, 2017 |
$$1,001 - $15,000 |
Aug. 18, 2017 |
|
Patty Murray
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Sale (Full)
|
June 15, 2017 |
$$1,001 - $15,000 |
June 22, 2017 |
|
James B. Renacci
|
house |
BRISTOL MYERS SQUIBB COMPANY (BMY) |
BMY |
STOCK |
PURCHASE
|
May 16, 2017 |
$$1,000 - $15,000 |
June 7, 2017 |
|
Lamar Smith
|
house |
bristol-Myers Squibb Company (bMY) |
BMY |
STOCK |
Sale
|
April 27, 2017 |
$$1,001 - $15,000 |
May 7, 2017 |
|
Lamar Smith
|
house |
bristol-Myers Squibb Company (bMY) |
BMY |
STOCK |
Sale
|
March 28, 2017 |
$$1,001 - $15,000 |
April 10, 2017 |
|
David A Perdue , Jr
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Purchase
|
March 22, 2017 |
$$1,001 - $15,000 |
March 31, 2017 |
|
Patty Murray
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Purchase
|
March 16, 2017 |
$$1,001 - $15,000 |
March 21, 2017 |
|
James B. Renacci
|
house |
BRISTOL MYERS SQUIRE COMPANY (BMY) |
BMY |
STOCK |
PURCHASE
|
March 7, 2017 |
$$15,001 - $50,000 |
March 21, 2017 |
|
James M Inhofe
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Sale (Partial)
|
Feb. 28, 2017 |
$$15,001 - $50,000 |
March 2, 2017 |
|
Sheldon Whitehouse
|
senate |
BMY-Bristol-Myers Squibb Company |
BMY |
STOCK |
Purchase
|
Feb. 23, 2017 |
$$1,001 - $15,000 |
March 15, 2017 |
|
Sheldon Whitehouse
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Purchase
|
Feb. 23, 2017 |
$$1,001 - $15,000 |
March 15, 2017 |
|
James B. Renacci
|
house |
BRISTOL MYERS SQUIBB COMPANY |
BMY |
STOCK |
PURCHASE
|
Feb. 8, 2017 |
$$1,001 - $15,000 |
Feb. 22, 2017 |
|
James M Inhofe
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Purchase
|
Feb. 1, 2017 |
$$15,001 - $50,000 |
March 2, 2017 |
|
John Hoeven
|
senate |
Bristol-Myers Squibb Company |
BMY |
STOCK |
Sale (Full)
|
Jan. 20, 2017 |
$$50,001 - $100,000 |
Jan. 25, 2017 |
|
James B. Renacci
|
house |
BRISTOL MYERS SQUIRRE COMPANY |
BMY |
STOCK |
PURCHASE
|
Jan. 20, 2017 |
$$15,001 - $50,000 |
Feb. 7, 2017 |